Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 161

1.

Corticosteroids for treating sepsis in children and adults.

Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y, Pirracchio R, Rochwerg B.

Cochrane Database Syst Rev. 2019 Dec 6;12:CD002243. doi: 10.1002/14651858.CD002243.pub4. Review.

PMID:
31808551
2.

Impact of a targeted monitoring on data-quality and data-management workload of randomized controlled trials: a prospective comparative study.

Fougerou-Leurent C, Laviolle B, Tual C, Visseiche V, Veislinger A, Danjou H, Martin A, Turmel V, Renault A, Bellissant E.

Br J Clin Pharmacol. 2019 Aug 31. doi: 10.1111/bcp.14108. [Epub ahead of print]

PMID:
31471967
3.

Modelling of the Time-Varying Pharmacokinetics of Therapeutic Monoclonal Antibodies: A Literature Review.

Petitcollin A, Bensalem A, Verdier MC, Tron C, Lemaitre F, Paintaud G, Bellissant E, Ternant D.

Clin Pharmacokinet. 2019 Aug 26. doi: 10.1007/s40262-019-00816-7. [Epub ahead of print] Review.

PMID:
31452150
4.

Immune Checkpoint Inhibitors in Melanoma: A Review of Pharmacokinetics and Exposure-Response Relationships.

Leven C, Padelli M, Carré JL, Bellissant E, Misery L.

Clin Pharmacokinet. 2019 Nov;58(11):1393-1405. doi: 10.1007/s40262-019-00789-7.

PMID:
31183812
5.

Multicentre, prospective, double-blind, randomised controlled clinical trial comparing different non-opioid analgesic combinations with morphine for postoperative analgesia: the OCTOPUS study.

Beloeil H, Albaladejo P, Sion A, Durand M, Martinez V, Lasocki S, Futier E, Verzili D, Minville V, Fessenmeyer C, Belbachir A, Aubrun F, Renault A, Bellissant E; OCTOPUS group.

Br J Anaesth. 2019 Jun;122(6):e98-e106. doi: 10.1016/j.bja.2018.10.058. Epub 2018 Dec 29.

PMID:
30915987
6.

Pharmacokinetic Parameters of Infliximab Influence the Rate of Relapse After De-Escalation in Adults With Inflammatory Bowel Diseases.

Petitcollin A, Brochard C, Siproudhis L, Tron C, Verdier MC, Lemaitre F, Lucidarme C, Bouguen G, Bellissant É.

Clin Pharmacol Ther. 2019 Sep;106(3):605-615. doi: 10.1002/cpt.1429. Epub 2019 Apr 29.

7.

Preliminary results of the Phase 1 Lip-Re I clinical trial: biodistribution and dosimetry assessments in hepatocellular carcinoma patients treated with 188Re-SSS Lipiodol radioembolization.

Delaunay K, Edeline J, Rolland Y, Lepareur N, Laffont S, Palard X, Bouvry C, Le Sourd S, Pracht M, Ardisson V, Noiret N, Bellissant É, Garin E.

Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1506-1517. doi: 10.1007/s00259-019-04277-9. Epub 2019 Feb 4.

PMID:
30715571
8.

Predictors of relapse following infliximab de-escalation in patients with inflammatory bowel disease: the value of a strategy based on therapeutic drug monitoring.

Lucidarme C, Petitcollin A, Brochard C, Siproudhis L, Dewitte M, Landemaine A, Bellissant E, Bouguen G.

Aliment Pharmacol Ther. 2019 Jan;49(2):147-154. doi: 10.1111/apt.15046.

PMID:
30589970
9.

Self-other recognition impairments in individuals with schizophrenia: a new experimental paradigm using a double mirror.

Keromnes G, Motillon T, Coulon N, Berthoz A, Du Boisgueheneuc F, Wehrmann M, Martin B, Thirioux B, Bonnot O, Ridereau R, Bellissant E, Drapier D, Levoyer D, Jaafari N, Tordjman S.

NPJ Schizophr. 2018 Nov 28;4(1):24. doi: 10.1038/s41537-018-0065-5.

10.

Tacrolimus Concentrations Measured in Excreted Bile in Liver Transplant Recipients: The STABILE Study.

Rayar M, Tron C, Locher C, Chebaro A, Beaurepaire JM, Blondeau M, Cusumano C, Bardou-Jacquet E, Houssel-Debry P, Camus C, Petitcollin A, Verdier MC, Lakéhal M, Desfourneaux V, Sulpice L, Meunier B, Bellissant E, Boudjema K, Lemaitre F.

Clin Ther. 2018 Dec;40(12):2088-2098. doi: 10.1016/j.clinthera.2018.10.015. Epub 2018 Nov 19.

PMID:
30467013
11.

Liposomal amphotericin B pharmacokinetics in a patient treated with extracorporeal membrane oxygenation.

Foulquier JB, Berneau P, Frérou A, Verdier MC, Saint-Marcoux F, Petitcollin A, Tron C, Bellissant E, Lemaitre F.

Med Mal Infect. 2019 Feb;49(1):69-71. doi: 10.1016/j.medmal.2018.10.011. Epub 2018 Nov 19. No abstract available.

PMID:
30466763
12.

Tacrolimus overexposure in kidney transplant recipients during the first post-operative week: caution is required in older patients.

Lemaitre F, Lorcy N, Tron C, Golbin L, Petitcollin A, Verdier MC, Vigneau C, Bellissant E.

Fundam Clin Pharmacol. 2019 Jun;33(3):347-354. doi: 10.1111/fcp.12432. Epub 2018 Dec 7.

13.

Pharmacogenetics of Membrane Transporters of Tacrolimus in Solid Organ Transplantation.

Tron C, Lemaitre F, Verstuyft C, Petitcollin A, Verdier MC, Bellissant E.

Clin Pharmacokinet. 2019 May;58(5):593-613. doi: 10.1007/s40262-018-0717-7. Review.

PMID:
30415459
14.

Tacrolimus diffusion across the peripheral mononuclear blood cell membrane: impact of drug transporters.

Tron C, Allard M, Petitcollin A, Ferrand-Sorre MJ, Verdier MC, Querzerho-Raguideau J, Blanchet B, Le Priol J, Roussel M, Deugnier Y, Bellissant E, Lemaitre F.

Fundam Clin Pharmacol. 2019 Feb;33(1):113-121. doi: 10.1111/fcp.12412. Epub 2018 Oct 14.

15.

Glucocorticoids with or without Fludrocortisone in Septic Shock.

Annane D, Renault A, Bellissant E.

N Engl J Med. 2018 Aug 30;379(9):895-6. doi: 10.1056/NEJMc1804993. No abstract available.

PMID:
30179381
16.

[ISO 9001certification of a quality management system in a clinical investigation center].

Chesnais J, Fougerou-Leurent C, Laforest C, Renault A, Bellissant E, Laviolle B.

Therapie. 2018 Dec;73(6):521-527. doi: 10.1016/j.therap.2018.04.005. Epub 2018 May 3. French.

17.

Modeling Immunization To Infliximab in Children With Crohn's Disease Using Population Pharmacokinetics: A Pilot Study.

Petitcollin A, Leuret O, Tron C, Lemaitre F, Verdier MC, Paintaud G, Bouguen G, Willot S, Bellissant E, Ternant D.

Inflamm Bowel Dis. 2018 Jul 12;24(8):1745-1754. doi: 10.1093/ibd/izy129.

PMID:
29788058
18.

Hydrocortisone plus Fludrocortisone for Adults with Septic Shock.

Annane D, Renault A, Brun-Buisson C, Megarbane B, Quenot JP, Siami S, Cariou A, Forceville X, Schwebel C, Martin C, Timsit JF, Misset B, Ali Benali M, Colin G, Souweine B, Asehnoune K, Mercier E, Chimot L, Charpentier C, François B, Boulain T, Petitpas F, Constantin JM, Dhonneur G, Baudin F, Combes A, Bohé J, Loriferne JF, Amathieu R, Cook F, Slama M, Leroy O, Capellier G, Dargent A, Hissem T, Maxime V, Bellissant E; CRICS-TRIGGERSEP Network.

N Engl J Med. 2018 Mar 1;378(9):809-818. doi: 10.1056/NEJMoa1705716.

19.

High Intrapatient Variability of Tacrolimus Exposure in the Early Period After Liver Transplantation Is Associated With Poorer Outcomes.

Rayar M, Tron C, Jézéquel C, Beaurepaire JM, Petitcollin A, Houssel-Debry P, Camus C, Verdier MC, Dehlawi A, Lakéhal M, Desfourneaux V, Meunier B, Sulpice L, Bellissant E, Boudjema K, Lemaitre F.

Transplantation. 2018 Mar;102(3):e108-e114. doi: 10.1097/TP.0000000000002052.

PMID:
29315140
20.

Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4: the ANRS HC32 QUATTRO study.

Roulot D, Thibault V, Laforest C, Fontaine H, Bronowicki JP, Asselah T, Bourlière M, Canva V, Leroy V, Loustaud-Ratti V, Ouzan D, Zoulim F, Schischmanoff O, Rousseau C, Renault A, Petrov-Sanchez V, Diallo A, Bellissant E, Serfaty L; ANRS HC32 QUATTRO study group.

Eur J Gastroenterol Hepatol. 2018 Mar;30(3):302-309. doi: 10.1097/MEG.0000000000001035.

PMID:
29271782
21.

Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study).

Rosenthal E, Fougerou-Leurent C, Renault A, Carrieri MP, Marcellin F, Garraffo R, Teicher E, Aumaitre H, Lacombe K, Bailly F, Billaud E, Chevaliez S, Dominguez S, Valantin MA, Reynes J, Naqvi A, Cotte L, Metivier S, Leroy V, Dupon M, Allegre T, De Truchis P, Jeantils V, Chas J, Salmon-Ceron D, Morlat P, Neau D, Perré P, Piroth L, Pol S, Bourlière M, Pageaux GP, Alric L, Zucman D, Girard PM, Poizot-Martin I, Yazdanpanah Y, Raffi F, Pabic EL, Tual C, Pailhé A, Amri I, Bellissant E, Molina JM; ANRS HC31 SOFTRIH Study Group.

HIV Med. 2018 Mar;19(3):227-237. doi: 10.1111/hiv.12571. Epub 2017 Dec 7.

PMID:
29214737
22.

Retreatment With Sofosbuvir Plus Grazoprevir/Elbasvir Plus Ribavirin of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed an NS5A- or NS3-Containing Regimen: The ANRS HC34 REVENGE Study.

de Lédinghen V, Laforest C, Hézode C, Pol S, Renault A, Alric L, Larrey D, Métivier S, Tran A, Jézéquel C, Samuel D, Zoulim F, Tual C, Pailhé A, Gibowski S, Bourlière M, Bellissant E, Pawlotsky JM.

Clin Infect Dis. 2018 Mar 19;66(7):1013-1018. doi: 10.1093/cid/cix916.

23.

Safety study and therapeutic drug monitoring of the oral tablet formulation of posaconazole in patients with haematological malignancies.

Boglione-Kerrien C, Picard S, Tron C, Nimubona S, Gangneux JP, Lalanne S, Lemaitre F, Bellissant E, Verdier MC, Petitcollin A.

J Cancer Res Clin Oncol. 2018 Jan;144(1):127-134. doi: 10.1007/s00432-017-2523-2. Epub 2017 Sep 20.

PMID:
28932906
24.

Population Pharmacokinetics of Posaconazole Tablets and Monte Carlo Simulations To Determine whether All Patients Should Receive the Same Dose.

Petitcollin A, Boglione-Kerrien C, Tron C, Nimubona S, Lalanne S, Lemaitre F, Bellissant E, Verdier MC.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e01166-17. doi: 10.1128/AAC.01166-17. Print 2017 Nov.

25.

Managing Drug-Drug Interaction Between Ombitasvir, Paritaprevir/Ritonavir, Dasabuvir, and Mycophenolate Mofetil.

Lemaitre F, Ben Ali Z, Tron C, Jezequel C, Boglione-Kerrien C, Verdier MC, Guyader D, Bellissant E.

Ther Drug Monit. 2017 Aug;39(4):305-307. doi: 10.1097/FTD.0000000000000397.

PMID:
28700519
26.

Melatonin: Pharmacology, Functions and Therapeutic Benefits.

Tordjman S, Chokron S, Delorme R, Charrier A, Bellissant E, Jaafari N, Fougerou C.

Curr Neuropharmacol. 2017 Apr;15(3):434-443. doi: 10.2174/1570159X14666161228122115. Review.

27.

Tacrolimus: Does direct glucuronidation matter? An analytical and pharmacological perspective.

Tron C, Petitcollin A, Verdier MC, Rayar M, Beaurepaire JM, Boudjema K, Bellissant E, Lemaitre F.

Pharmacol Res. 2017 Oct;124:164-166. doi: 10.1016/j.phrs.2017.03.027. Epub 2017 Mar 31. No abstract available.

28.

Population Pharmacokinetic-Pharmacodynamic Model of Oral Fludrocortisone and Intravenous Hydrocortisone in Healthy Volunteers.

Hamitouche N, Comets E, Ribot M, Alvarez JC, Bellissant E, Laviolle B.

AAPS J. 2017 May;19(3):727-735. doi: 10.1208/s12248-016-0041-9. Epub 2017 Jan 12.

PMID:
28083797
29.

Ex Vivo Model to Decipher the Impact of Extracorporeal Membrane Oxygenation on Beta-lactam Degradation Kinetics.

Leven C, Fillâtre P, Petitcollin A, Verdier MC, Laurent J, Nesseler N, Launey Y, Tattevin P, Bellissant E, Flécher E, Lemaitre F.

Ther Drug Monit. 2017 Apr;39(2):180-184. doi: 10.1097/FTD.0000000000000369.

PMID:
28033162
30.

A high performance liquid chromatography tandem mass spectrometry for the quantification of tacrolimus in human bile in liver transplant recipients.

Tron C, Rayar M, Petitcollin A, Beaurepaire JM, Cusumano C, Verdier MC, Houssel-Debry P, Camus C, Boudjema K, Bellissant E, Lemaitre F.

J Chromatogr A. 2016 Dec 2;1475:55-63. doi: 10.1016/j.chroma.2016.10.075. Epub 2016 Oct 29.

31.

Metabolic and hepatic effects of bloodletting in dysmetabolic iron overload syndrome: A randomized controlled study in 274 patients.

Lainé F, Ruivard M, Loustaud-Ratti V, Bonnet F, Calès P, Bardou-Jacquet E, Sacher-Huvelin S, Causse X, Beusnel C, Renault A, Bellissant E, Deugnier Y; Study Group.

Hepatology. 2017 Feb;65(2):465-474. doi: 10.1002/hep.28856. Epub 2016 Nov 10.

32.

ITPA deficiency and ribavirin level are still predictive of anaemia in HCV-HIV-coinfected patients receiving ribavirin combined with a first-generation DAA (ANRS HC27 study).

Kheloufi F, Poizot-Martin I, Garraffo R, Tavenard A, Quaranta S, Renault A, Lavrut T, Bourlière M, Halfon P, Piroth L, Bellissant E, Lacarelle B, Molina JM, Solas C; ANRS HC27 BOCEPREVIH Study Group.

Antivir Ther. 2017;22(6):461-469. doi: 10.3851/IMP3074. Epub 2016 Sep 1.

PMID:
27583701
33.

Erratum to: Design and conduct of the activated protein C and corticosteroids for human septic shock (APROCCHSS) trial.

Annane D, Brun-Buisson C, Cariou A, Martin C, Misset B, Renault A, Lehmann B, Millul V, Maxime V, Bellissant E; APROCCHSS Investigators for the TRIGGERSEP Network.

Ann Intensive Care. 2016 Dec;6(1):79. doi: 10.1186/s13613-016-0165-1. Epub 2016 Aug 19. No abstract available.

34.

Increased inhibition of cytochrome P450 3A4 with the tablet formulation of posaconazole.

Petitcollin A, Crochette R, Tron C, Verdier MC, Boglione-Kerrien C, Vigneau C, Bellissant E, Lemaitre F.

Drug Metab Pharmacokinet. 2016 Oct;31(5):389-393. doi: 10.1016/j.dmpk.2016.05.001. Epub 2016 May 13.

35.

Pharmacokinetics of oral fludrocortisone in septic shock.

Polito A, Hamitouche N, Ribot M, Polito A, Laviolle B, Bellissant E, Annane D, Alvarez JC.

Br J Clin Pharmacol. 2016 Dec;82(6):1509-1516. doi: 10.1111/bcp.13065. Epub 2016 Aug 22.

36.

Design and conduct of the activated protein C and corticosteroids for human septic shock (APROCCHSS) trial.

Annane D, Buisson CB, Cariou A, Martin C, Misset B, Renault A, Lehmann B, Millul V, Maxime V, Bellissant E; APROCCHSS Investigators for the TRIGGERSEP Network.

Ann Intensive Care. 2016 Dec;6(1):43. doi: 10.1186/s13613-016-0147-3. Epub 2016 May 6. Erratum in: Ann Intensive Care. 2016 Dec;6(1):79.

37.

Estimated glomerular filtration rate but not solute carrier polymorphisms influences anemia in HIV-hepatitis C virus coinfected patients treated with boceprevir or telaprevir-based therapy.

Kheloufi F, Bellissant E, Cotte L, Poizot-Martin I, Quaranta S, Garraffo R, Barrail-Tran A, Renault A, Fournier I, Lacarelle B, Bourlière M, Molina JM, Solas C; ANRS HC27 BOCEPREVIH & HC26 TELAPREVIH Study Groups.

AIDS. 2016 Aug 24;30(13):2085-90. doi: 10.1097/QAD.0000000000001143.

PMID:
27149089
38.

Addition of boceprevir to PEG-interferon/ribavirin in HIV-HCV-Genotype-1-coinfected, treatment-experienced patients: efficacy, safety, and pharmacokinetics data from the ANRS HC27 study.

Poizot-Martin I, Bellissant E, Garraffo R, Colson P, Piroth L, Solas C, Renault A, Bourlière M, Halfon P, Ghosn J, Alric L, Naqvi A, Carrieri P, Molina JM; ANRS HC27 BOCEPREVIH Study Group.

HIV Clin Trials. 2016 Mar;17(2):63-71. doi: 10.1080/15284336.2015.1135553. Epub 2016 Feb 11.

39.

Effect of a Perioperative Nutritional Supplementation with Oral Impact® in Patients undergoing Hepatic Surgery for Liver Cancer: A Prospective, Placebo-Controlled, Randomized, Double-Blind Study.

Seguin P, Locher C, Boudjema K, Hamon C, Mouchel C, Malledant Y, Bellissant E.

Nutr Cancer. 2016;68(3):464-72. doi: 10.1080/01635581.2016.1153670. Epub 2016 Mar 23.

40.

Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials.

Palpacuer C, Laviolle B, Boussageon R, Reymann JM, Bellissant E, Naudet F.

PLoS Med. 2015 Dec 22;12(12):e1001924. doi: 10.1371/journal.pmed.1001924. eCollection 2015 Dec. Review.

41.

Should we fear tubing adsorption of antibacterial drugs in extracorporeal membrane oxygenation? An answer for cephalosporins and carbapenems.

Tron C, Leven C, Fillâtre P, Maillard N, Nesseler N, Tattevin P, Flecher E, Bellissant E, Verdier MC, Lemaitre F.

Clin Exp Pharmacol Physiol. 2016 Feb;43(2):281-3. doi: 10.1111/1440-1681.12527. No abstract available.

42.

Corticosteroids for treating sepsis.

Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y.

Cochrane Database Syst Rev. 2015 Dec 3;(12):CD002243. doi: 10.1002/14651858.CD002243.pub3. Review.

43.

Stability Study of Isoniazid in Human Plasma: Practical Aspects for Laboratories.

Tron C, Lemaitre F, Pollock D, Briand Y, Lelièvre P, Boglione-Kerrien C, Bellissant E, Verdier MC.

Ther Drug Monit. 2015 Dec;37(6):831-3. doi: 10.1097/FTD.0000000000000218. No abstract available.

PMID:
25945417
44.

Autism as a disorder of biological and behavioral rhythms: toward new therapeutic perspectives.

Tordjman S, Davlantis KS, Georgieff N, Geoffray MM, Speranza M, Anderson GM, Xavier J, Botbol M, Oriol C, Bellissant E, Vernay-Leconte J, Fougerou C, Hespel A, Tavenard A, Cohen D, Kermarrec S, Coulon N, Bonnot O, Dawson G.

Front Pediatr. 2015 Feb 23;3:1. doi: 10.3389/fped.2015.00001. eCollection 2015. Review.

45.

Controlled Attenuation Parameter and Liver Stiffness Measurements for Steatosis Assessment in the Liver Transplant of Brain Dead Donors.

Mancia C, Loustaud-Ratti V, Carrier P, Naudet F, Bellissant E, Labrousse F, Pichon N.

Transplantation. 2015 Aug;99(8):1619-24. doi: 10.1097/TP.0000000000000652.

PMID:
25719261
46.

Lack of drug interaction between cyclosporine and telaprevir in a liver transplant recipient.

Lemaitre F, Jezequel C, Verdier MC, Dermu M, Boglione-Kerrien C, Boudjema K, Bellissant E.

Transpl Infect Dis. 2015 Feb;17(1):106-10. doi: 10.1111/tid.12335. Epub 2015 Jan 9.

PMID:
25573697
47.

Pharmacokinetics and pharmacodynamics of tacrolimus in liver transplant recipients: inside the white blood cells.

Lemaitre F, Blanchet B, Latournerie M, Antignac M, Houssel-Debry P, Verdier MC, Dermu M, Camus C, Le Priol J, Roussel M, Zheng Y, Fillatre P, Curis E, Bellissant E, Boudjema K, Fernandez C.

Clin Biochem. 2015 Apr;48(6):406-11. doi: 10.1016/j.clinbiochem.2014.12.018. Epub 2015 Jan 3.

48.

[Impact of a regional pharmacovigilance network on notification of adverse drug reactions: results at 3 years].

Picard S, Polard E, Oger E, Bellissant E.

Therapie. 2015 May-Jun;70(3):293-9. doi: 10.2515/therapie/2014216. Epub 2014 Dec 24. French.

PMID:
25534522
49.

Use of very-high-dose olanzapine in treatment-resistant schizophrenia.

Batail JM, Langrée B, Robert G, Bleher S, Verdier MC, Bellissant E, Millet B, Drapier D.

Schizophr Res. 2014 Nov;159(2-3):411-4. doi: 10.1016/j.schres.2014.09.020. Epub 2014 Sep 30.

50.

Suspicion of interaction between maribavir and everolimus in a renal transplant recipient.

Verdier MC, Patrat-Delon S, Lemaitre F, Revest M, Rivalan J, Michelet C, Bellissant E.

Transplantation. 2014 Aug 15;98(3):e20-1. doi: 10.1097/TP.0000000000000275. No abstract available.

PMID:
25089341

Supplemental Content

Loading ...
Support Center